During the past decade, Emory Cystic Fibrosis Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory Cystic Fibrosis Center" #1 sponsor was "PTC Therapeutics" with 2 trials, followed by "Seattle Children's Hospital" with 2 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 2 trials sponsored, "Atlanta VA Medical Center" with 1 trials sponsored and "CF Therapeutics Development Network Coordinating Center" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory Cystic Fibrosis Center" #1 collaborator was "Cystic Fibrosis Foundation" with 8 trials as a collaborator, "CF Therapeutics Development Network Coordinating Center" with 1 trials as a collaborator, "Emory University" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Emory Cystic Fibrosis Center" are "Cystic Fibrosis" (10 trials), "Exocrine Pancreatic Insufficiency" (1 trials), "Growth Failure" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Emory Cystic Fibrosis Center" in a lesser frequency.

Most popular intervention types in "Emory Cystic Fibrosis Center" are "Drug" (7 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ataluren" (2 trials), "Ivacaftor" (2 trials), "AZLI" (1 trials) and "Docosahexaenoic acid (DHA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Emory Cystic Fibrosis Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Emory Cystic Fibrosis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Emory Cystic Fibrosis Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Emory Cystic Fibrosis Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".